A commonly prescribed cholesterol-lowering drug, called pitavastatin, could be used to treat patients with triple-negative breast cancer, after researchers found that it has the ability to block a key cancer survival protein.
A…
Pitavastatin identified as potential treatment for triple-negative breast cancer
